Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion

Journal of Korean Medical Science

Volumn 30, Issue 4, 2015, Pages 475-482

  Kim, Sang Jin ^a   Yoon, Young Hee ^b   Kim, Ha Kyoung ^c   Yoon, Hee Seong ^d   Kang, Se Woong ^a   Kim, June Gone ^b   Park, Kyu Hyung ^e   Jo, Young Joon ^f   Lee, Dong Hoon ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Hallym University   (South Korea)

^d St Mary's Eye Hospital   (South Korea)

^e Seoul National University Bundang Hospital   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

Author keywords

Macular edema; Retinal vein occlusion; Tomography, optical coherence; Vascular endothelial growth factor A; Visual acuity

Indexed keywords

ADULT; AGED; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; RETINA VEIN OCCLUSION; VISUAL ACUITY;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; RETINA; RETINAL VEIN OCCLUSION; VISUAL ACUITY;

EID: 84951842997     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2015.30.4.475     Document Type: Article

References (17)

1. Wong TY, Scott IU. Clinical practice. Retinal-vein occlusion. N Engl J Med 2010; 363: 2135-44.
2. Rogers SL, McIntosh RL, Lim L, Mitchell P, Cheung N, Kowalski JW, Nguyen HP, Wang JJ, Wong TY. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117: 1094-101.e5.
3. McIntosh RL, Rogers SL, Lim L, Cheung N, Wang JJ, Mitchell P, Kowalski JW, Nguyen HP, Wong TY. Natural history of central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2010; 117: 1113-23.e15.
4. Campochiaro PA, Heier JS, Feiner L, Gray S, Saroj N, Rundle AC, Murahashi WY, Rubio RG; BRAVO Investigators. Ranibizumab for macular edema following branch Ophthalmology 2010; 117: 1102-12.e1.
5. Brown DM, Campochiaro PA, Singh RP, Li Z, Gray S, Saroj N, Rundle AC, Rubio RG, Murahashi WY; CRUISE Investigator. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010; 117: 1124-33.e1.
6. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jiao J, Li XY, et al.; Ozurdex GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology 2011; 118: 2453-60.
7. Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M, et al.; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol 2009; 127: 1115-28.
8. Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH, et al.; SCORE Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. Arch Ophthalmol 2009; 127: 1101-14.
9. Scott IU, VanVeldhuisen PC, Oden NL, Ip MS, Blodi BA, Hartnett ME, Cohen G, Standard Care versus COrticosteroid for REtinal Vein Occlusion Study Investigator Group. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology 2011; 118: 345-52.
10. Lee JY, Yoon YH, Kim HK, Yoon HS, Kang SW, Kim JG, Park KH, Jo YJ; Korean RVO Study. Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group. J Korean Med Sci 2013; 28: 136-44.
11. Kiernan DF, Hariprasad SM. Normative databases in SD-OCT: a status report Available at http://www.retinalphysician.com/articleviewer.aspx?articleID=104438 [accessed on 1 March 2012].
12. Heussen FM, Ouyang Y, McDonnell EC, Narala R, Ruiz-Garcia H, Walsh AC, Sadda SR. Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments. Br J Ophthalmol 2012; 96: 380-5.
13. The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984; 98: 271-82.
14. Ip MS, Oden NL, Scott IU, VanVeldhuisen PC, Blodi BA, Figueroa M, Antoszyk A, Elman M; SCORE Study Investigator Group. SCORE Study report 3: study design and baseline characteristics. Ophthalmology 2009; 116: 1770-7.e1.
15. Klein R, Klein BE, Moss SE, Meuer SM. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000; 98: 133-41; discussion 41-3.
16. Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology 2009; 116: 497-503.
17. Thorne JE, Daniel E, Jabs DA, Kedhar SR, Peters GB, Dunn JP. Smoking as a risk factor for cystoid macular edema complicating intermediate uveitis. Am J Ophthalmol 2008; 145: 841-6.